Sudbury, MA, United States of America

Brett Granger

Average Co-Inventor Count = 7.8

ph-index = 7

Forward Citations = 106(Granted Patents)

Forward Citations (Not Self Cited) = 34(Sep 21, 2024)


Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

28 patents (USPTO):
1 patent (CIPO):

Title: Brett Granger: Innovator in Biopharmaceuticals and Patent Law

Introduction: Brett Granger, based in Sudbury, MA, is an accomplished inventor with a remarkable portfolio of 27 patents. His work primarily revolves around significant biopharmaceutical innovations aimed at addressing various medical disorders.

Latest Patents: Among his most notable inventions are two cutting-edge patents. The first is focused on Apoptosis signal-regulating kinase 1 (ASK-1) inhibitors. This invention introduces compounds that inhibit ASK-1, which is linked to autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, and cardiovascular diseases. The patent outlines pharmaceutical compositions for treating conditions associated with ASK-1, particularly non-alcoholic fatty liver disease (NAFLD) and non-alcohol steatohepatitis (NASH). The second patent addresses bile acid derivatives functioning as FXR/TGR5 agonists. It presents compounds designed to treat FXR-mediated or TGR5-mediated diseases. This invention also includes pharmaceutical compositions and usage methods for these compounds.

Career Highlights: Brett Granger has made significant contributions through his roles at various companies. He has developed his expertise while working with Enanta Pharmaceuticals, Inc., where he contributed to crucial biopharmaceutical advancements. Additionally, he has been associated with Elmore Patent Law Group, P.C., showcasing his dual proficiency in both invention and patent law.

Collaborations: In his career, Brett has collaborated with renowned professionals, including Guoqiang Wang and Yat Sun Or. These collaborations have further enhanced his capabilities in developing innovative solutions in the biopharmaceutical field.

Conclusion: Brett Granger stands out as a pivotal figure in both innovation and patent law. With his extensive patent portfolio and collaborations, he continues to address complex medical challenges through groundbreaking inventions. His work not only contributes to scientific advancement but also illustrates the crucial intersection of innovation and intellectual property management in the biopharmaceutical sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…